(1)
Bedier, H.; Isnard, S.; Maedler-Kron, C.; Routy, J.-P. Long-Term Tolerance and Efficacy of Siltuximab (anti-IL-6) in a Young Adult With Idiopathic Multicentric Castleman Disease During COVID-19. EJCRIM 2023, 10 (12). https://doi.org/10.12890/2023_004098.